BIOLATAM 2013 will feature a program of conferences addressing the following topics:
Conferences, December 9th
“VENTURE CAPITAL SEMINAR”
Monday, December 9th – 9h00-15h00
Room 1
- Success stories in public-private funding
- Opportunities for cross participation between Europe, USA and LATAM
- How to attract private wealth & business angels to the biotech industry
Chairwoman:
- Cristina Garmendia, Former Spanish Minister of Science and Innovation (Spain)
Part 1 (9h00-10h30): Public policies to support biotech Venture Capital
Moderator:
- MatTeo Grazzi, Specialist in the Competitiveness and Innovation Division, Inter-American Development Bank, (USA-DC)
Confirmed Speakers:
- Catalina Ortiz, General Manager, INNPULSA COLOMBIA (Colombia)
- Elisa Robles, General Director, CDTI (Spanish Center for the Development of Industrial Technology)- Innvierte Program (Spain). "Venture Capital Initiatives for Technology Companies"
- Consuelo Valverde, Founder, SV LATAM FUND (USA-CA)
- Felipe Camposano, General Partner, AUSTRAL CAPITAL & President, ASEMBIO - Chilean Association of Biotechnology Companies (Chile) "What we need to build a Biotech Industry in Latin America"
Part 2 (10h30-12h00): Biotech Venture Capital: the experience of international investors
Moderator:
- Joël Jean-Mairet, Managing Partners, YSIOS CAPITAL PARTNERS (Spain)
Confirmed Speakers:
- Gilles Nobercourt , Partner, EDMOND DE ROTHSCHILD (France)
- Sander Slootweg, Managing Partner, FORBION CAPITAL PARTNERS (Netherlands)
- Arun R. Jayadev, Principal, WELLINGTON PARTNERS (United Kingdom)
Part 3 (13h30-15h00): What investors seek in the latinamerican biotechnology
Moderator:
- Ángel Santos, Director of Business Development, CRB INVERBÍO SGECR (Spain)
Confirmed Speakers:
- João Paulo Poiares Baptista, Managing Director, BURRILL BRASIL GESTÃO DE RECURSOS S.A. (Brazil)
- Santiago de Torres, President, INVEREADY BIOTECH II SCR (Spain). "Venture capital as a lever of growth for biotech companies. Risks and strengths"
- Susanna Mesa, Senior Associate, THE TROUT GROUP LLC (USA-NY). "What makes biotechnology companies attractive to US investors"
“BIOSIMILARS”
Monday, December 9th – 10h30-12h00
Room 2
- Regulatory environment
- Experiences in manufacturing
- Situation and outlook in Latin America
Moderator
- Katherine Garzón, Manager, BIOTECHNOVA SAS (Colombia)
Confirmed Speakers:
- Oriol Argemi, Responsible of Business Development, GRIFOLS ENGINEERING S.A. (Spain). "Design of Protein Manufacturing Plant"
- Erick Sabido Ruiz, Biotechnology Division Manager, SARTORIUS DE MÉXICO S.A. (Mexico). "Efficient and Flexible Facilities for the production of Vaccines and mAb's"
- Sundar Ramanan, R&D Policy AMGEN INC (USA-CA). "Realizing the Full Potential of Biosimilars"
- Edita Mistiniene, Scientific Director, 3P BIOPHARMACEUTICALS S.L. (Spain)
“PERSONALIZED MEDICINE BASED ON BIOMARKERS AGAINST CANCER”
Monday, December 9th – 13h30-15h00
Room 2
- Assessment of the results of the study "Cancer Control Planning in Latin America and the Caribbean" published by Lancet Oncology
- Population screening strategies
- Early & Cost effective diagnostic & pronostic systems
- Juan Carlos Alvarez, Social Policies Department Adviser, Spanish Government Presidency Cabinet (Spain)
Confirmed Speakers:
- Gabriela Cezar, Senior Director and Head, External R&D Innovation, Brazil, Latin America & South Africa, PFIZER (Brazil). "A key role for Latin America in global Precision Medicine R&D"
- Patricio Manque, Dean of the Faculty of Sciences& Director of the Center for Genomics and Bioinformatics, Universidad Mayor (Chile). "miRNAs as biomarkers for disease"
- María del Carmen Álvarez-Buylla Roces, Liaison and Institutional Development Manager, INMEGEN-Instituto Nacional de Medicina Genómica (Mexico)
- Augusto G. Silva, R & D Director, ALTHIA HEALTH (Spain). "New Predictor Models Under Personalized Medicine Scope"
“TOWARDS A SUSTAINABLE BIOECONOMY FOR LATIN AMERICA”
Monday, December 9th – 15h00-16h30
Room 2
- Bioeconomy Strategy of the European Union: Opportunities for Latin America in the framework of Horizon 2020. What is there for Latin America?
- Market trends in Biofuels
- Bioplastics: Opportunities in a growing market
Moderator:
- Carlos Eduardo Calmanovici, President, ANPEI - Associação Nacional de Pesquisa e Desenvolvimento das Empresas Innovadoras (Brazil)
Confirmed Speakers:
- Javier Velasco, CEO, NEOL BIOSOLUTIONS S.A. (Spain)
- Roberto Horcajada, Project Dept. Sub-Director & International Projects Manager, INKEMIA IUCT GROUP S.A. (Spain). "Renewable feedstocks, one of the bases of industrial biotechnology for biorefineries, biofuels and high added value products"
- Aleck Santamaría de la Cruz, General Manager, BIOENERGY S.A. (Colombia). "Biofuels: an alternative in the transport sector"
- Antonio José Vallespir, Executive Vice President - Institutional Affairs Europe, ABENGOA BIOENERGY (Spain)
“ADVANCED THERAPIES”
Monday, December 9th – 15h00-16h30
Room 2
- The role of organ donation and transplantation systems in the light of the challenge presented by regenerative medicine
- Map of scientific excellence in Latin America
- Opportunities in the field of private health providers
Moderator:
- Bernardo Camacho, Scientific Director, Distrital Health Secretariat of Bogotá (Colombia)
Confirmed Speakers:
- Gabriel Márquez, Technologies Manager, GENETRIX S.L. (Spain). "Regenerative Strategies for Myocardial Regeneration"
- José Terencio, COO, GRI-CEL (Spain). "Recent Advances in Gene Therapy"
- Matías Vial Valdés, General Manager, CELLS FOR CELLS S.A. (Chile)
“AGROBIOTECHNOLOGY”
Monday, December 9th – 16h30-18h00
Room 1
- Situation in Europe & in the U.S.A
- Is there room for Biotech SMEs?
- Crops of interest in Latin America
Moderator
- Albert Sasson, President, BIOEUROLATINA (France)
Confirmed Speakers:
- Marianela García-Siverio, Business Development Executive, CIGB - Cuban Center for Genetic Engineering and Biotechnology (Cuba). "Agribiotechnology in Cuba. Practical experience at CIGB."
- Alexander Grobman, President, ETHANO PERU LLC (Peru)
- Adriana Gutiérrez, Secretary for Science, Technology & Innovation, Secretariat for Science, Technology and Innovation of the Cundinamarca Governance (Colombia)
- Carlos Simancas, District Secretary for Economic Development, Bogota Economic Development Secretariat (Colombia)
"BIOBASED MEDICAL DEVICES"
Monday, December 9th – 16h30–18h30
Room 2
- Biomedical innovation and entrepreneurship
- Future of medical devices based on biotechnology
- In vitro diagnostics for infectious diseases
Moderator
- Hugo Fernando Villegas, President for Latam Area, COVIDIEN (USA -MA)
Confirmed Speakers
Diagnostics:
- Juan Carlos Briceño, Director, Biomedical Engineering Department of Los Andes University (Colombia). "Innovation and Entrepreneurship in Biomedical Engineering at Uniandes"
- Walter García, Deputy Chief Medical Officer, Biotechnology Research, LABORATORIOS SILANES SA de CV (Mexico). "Molecular Diagnosis and Pharmacogenomics in Mexico"
- Maria Tuominen, Key Account Manager, International Sales, BIOHIT HEALTHCARE (Finland). "GastroPanel test for the primary diagnostics of stomach health"
- Eduardo Giacomazzi, Deputy Coordinator, COMITÊ DA CADEIA PRODUTIVA DE BIOTECNOLOGIA - COMBIO at FIESP (Brazil). "Brazilian LIfe Science and Medical Devices Map. Convergency and Challenges for the future."
Medical Technologies:
- Xavier Abad Lloret, Product Manager, BTI BIOTECHNOLOGY INSTITUTE (Spain). "Regenerative and personalized medicine: therapeutic solutions"
- Mauricio Orozco-Levi, Head of Pneumology Service, FUNDACIÓN CARDIOVASCULAR DE COLOMBIA (Colombia). "Two New Medical Devices for Respiratory Therapy of Adults and Pediatric Patients: Oxygen Fraction Control (Controlizer) and Airflow Vibration (BURTER)"
- Mauricio Alberto Lizarazo, General Manager, OSTEOPHOENIX (Spain). "Design and production of customized osteosynthesis devices and reconstructive medicine. Future or history?"
Conferences, December 10th
“BIOTECHNOLOGY FOR COSMETICS”
Tuesday, December 10th – 8h00-9h30
Room 1
- Strategies for finding new natural extracts
- In vitro assay technologies
- Nanotech Solutions
Moderator:
-
Jaime Mauricio Concha, Managing Director, ANDI, National Business Association of Colombia (Colombia)
Confirmed Speakers:
- Carlos Moro, Presidente, ABROBIOTEC S.L. (Matarromera Group) (Spain)
- Alba Lucía Valenzuela, Head of Efficacy & Safety in Vitro Laboratory, BELCORP (Colombia)
- Oscar Expósito, CSO, PHYTURE BIOTECH S.L. (Spain). "Plant Stem Cell Technology: an eco -sustainable tool for obtaining a new generation of plant extracts with high added value for its application in dermocosmetics"
"NEGLECTED DISEASES"
Tuesday, December 10th – 8h00-9h30
Room 2
- Treatment of neglected diseases: an opportunity for biotech companies
- Excellence research in the field of neglected diseases
- Main challenges and advances in research and innovation in this area
Moderator:
- Elkin Osorio, Promotion & Prevention Manager, COLOMBIAN MINISTRY OF HEALTH AND SOCIAL PROTECTION (Colombia)
Confirmed Speakers:
- Isabel Amat, RUTI Vaccine Co-Inventor, ARCHIVEL FARMA S.L. (Spain)
- Walter García, Medical Director, INSTITUTO BIOCLON (Mexico). "Anascorp, the successful development of an antivenom for the treatment of an orphan disease"
- Silvio Wandalsen, Technical Director, BIOCLIN (Brazil)
- Sofía Duque Beltrá, Parasitology Group Coordinator, Branch of Scientific and Technological Research, Direction of Public Health Research, COLOMBIAN MINISTRY OF HEALTH AND SOCIAL PROTECTION (Colombia). "Onchocerciasis Elimination in Colombia"
- Águeda Cabello, General Manager of Health Surveillance, Paraguay's Ministry of Public Health and Social Wellbeing (Paraguay)
"LATIN DIASPORA: SUCCESSFUL LATINAMERICAN BIOENTREPRENEURS AROUND THE WORLD"
Tuesday, December 10th – 9h30-11h00
Room 1
Moderator:
- Joseph Fernández, CEO, ACTIVE MOTIF (USA -CA)
Confirmed Speakers:
- Willy A. Valdivia-Granda, Founder & CEO, ORION INTEGRATED BIOSCIENCES INC (USA -NJ). "Developing an Innovation Environment to Integrate Diagnostics, Prophylactics and Therapeutics"
- Carlos Encinas, CFO & VP for Business Development, AMERSTEM INC (USA-CA)
- Julio Castro, CEO, PALO BIOFARMA S.L. (Spain). "Coffee and Caffeine: Opportunities for the development of new medicines"
- Esteban Pombo Villar, COO, OXFORD BIOTHERAPEUTICS LTD (United Kingdom)
“FOOD BIOTECHNOLOGY, THE BIG BET”
Tuesday, December 10th – 9h30-11h00
Room 2
- Tools for quality control and traceability
- Latest developments in fermentation & probiotics
- Functional ingredients and nutrigenomics
Moderator:
- Sandra Rodríguez, Technology Intelligence Manager, CLARKE, MODET & Co (Spain)
Confirmed Speakers:
- Daniel Ramón, Consejero Delegado, BIOPOLIS S.L. (Spain)
- Gianfranco Grompone , Director Científico, DANONE RESEARCH (France). "New models for probiotic screening: a synergic study case between Europe and Latin America"
- Pablo Ortiz, Market Strategy Manager, OWL METABOLOMICS (Spain)
- Bernadette Klotz, General Manager, ALPINA CORPORATIVO (Colombia)
- Surendra Surejdeo-Maharaj, Plant Pathologist, COCOA RESEARCH CENTRE (Trinidad and Tobago). "Understanding the Potential of Cocoa Through Innovation and Commercialization"
“BIOPROSPECTING AND BIODIVERSITY”
Tuesday, December 10th – 13h30-15h00
Room 1
- Regulatory Status
- Opportunities in marine and terrestrial prospection
- Success stories in the sustainable management of biodiversity
Moderator:
- Óscar Manuel Cobar Pinto, Dean of the Faculty of Chemical & Pharmaceutical Sciences, Universidad de San Carlos de Guatemala (Guatemala)
Confirmed Speakers:
- María Mercedes Zambrano, Scientific Director, Corporación CORPOGEN (Colombia)
- Laura Charry, Business Development for South America, MAGELLAN BIOSCIENCE GROUP INC (USA-FL). "Development of sustainable technologies through marine microorganisms"
- Olga Genilloud, Scientific Director, FUNDACIÓN MEDINA (Spain). "Prospection and valorization of microbial biodiversity at Fundacion MEDINA"
- Jorge Huete-Pérez, President, NICARAGUAN ACADEMY OF SCIENCES (Nicaragua)
“THE IMPACT OF BIOTECHNOLOGY IN ANIMAL HEALTH AND AQUACULTURE”
Tuesday, December 10th – 13h30-15h00
Room 2
- New vaccines
- Diagnostic Systems
- Genomic technology applied to the sector
- New sources of supply
Moderator:
- Belén Barreiro, Marketing Manager, IMMUNOLOGY AND APPLIED GENETICS S.A. - INGENASA (Spain)
Confirmed Speakers:
- Pedro Bustamante–Gallardo, IBPG LTDA (Biotechnology & Genomic Platform) (Chile)
- Alfredo Sánchez, Sales Manager, VECOL S.A. (Colombia)
- Mirko Zimic Head Bioinformatics Group, FARVET S.A.C. (Peru).). "New technologies for the development of safer and more efficient avian vaccines"
- Geraldine Mlynarz, Gerente, ACTIVAQ S.A. (Chile)
Tuesday, December 10th – 13h30-15h00
Room 1
- The regulatory diversity in LATAM
- The critical role of distributors
- Success stories
Moderator:
- Christian López-Silva, Head of Pharmaceuticals & Life Sciences, Baker & McKenzie (Mexico)
Confirmed Speakers:
- Antonio Vila-Coro, Head of Business Development, VIVOTECNIA RESEARCH S.L. (Spain). "GLP Drug Development as a requirement to access EU and USA markets"
- Mario Alanis Garza, International Affairs Manager, COFEPRIS- Federal Commission for the Protection against Sanitary Risk (Mexico)
- Claudia Patricia Vaca, Adviser, Colombian Ministry of Health and Social Protection (Colombia)
- Henrique Kruger Frizzo, Attorney at Law, TRENCH, ROSSI E WATANABE ADVOGADOS (Brazil). "Brazilian Market and the Government as a Relevant Stakeholder".
"BIOENTREPRENEURIAL COLOMBIA"
Tuesday, December 10th – 14h00-16h00
Room 2
The Main Character in Biolatam, Know 8 from the hottest Biotech Companies in Colombia
Moderator:
- Carlos Estévez, Biohacker, LABORATORIO DE INVESTIGACIÓN EN SISTEMAS INTELIGENTES BIOLISI (Colombia)
- Jorge Soto, CEO, KERADERM (Colombia)
- Jorge Mario Giraldo, CEO, INBIOTECH (Colombia) o Germán Castaño, CEO, SOLAR CIENCIA AGRÍCOLA (Colombia)
- Camila Lecaros, GP- Investor, NAZCA VENTURES (Colombia)
- Patricia del Portillo, Executive Director, Corporación CORPOGEN (Colombia)
- Gloria Niño, CEO, SATECH (Colombia)
- Susana Fiorentino, CEO, PHAIRILAB (Colombia)
- Xavier Fargetton, CEO, ARCANATURA (Colombia)
“BIOTECH CLUSTER POLICIES IN LATIN AMERICA”
Tuesday, December 10th – 15h30-17h30
Room 1
- The role of industry associations
- Bioparks & Bioincubators
- International networks
Chairwoman:
- Elisa Robles, General Manager, CDTI-Spanish Center for the Development of Industrial Technology (Spain)
Moderator:
- Cristina Rechy, Section of Competitiveness, Innovation and Technology, OAS-Organization of American States (USA-DC)
Confirmed Speakers:
- Gabriela Couto, Founder & Director, MARKETPLAZA COSTA RICA (Costa Rica). "LatinAmerican Biotech: our potential in the world´s biotech industry"
- Vanessa Silva da Silva, Executive Coordinator, AMBIOTEC, Associação Mineira de Empresas de Biotecnologia e Ciéncias da Vida (Brazil)
- Nuno Arantes-Oliveira, President, P-BIO (Associaçao Portuguesa de Bioindústria) (Portugal). "Clustering in Portugal: finding critical mass in a small country"
- Victor Fuentes Tassara, Regional Manager, CORFO - Chilean Economic Development Agency (Chile)
- Óscar Manuel Cobar Pinto, Dean of the Faculty of Chemical & Pharmaceutical Sciences, Universidad de San Carlos de Guatemala (Guatemala)
- Cecilia Pérez, Sectorial Coordinator, URUGUAY XXI (Uruguay). "Biotechnology Sectorial Council- Uruguayan Experience"
- Lisa Melton, News editor, Nature Biotechnology (United Kingdom)
- Jorge Andrés Muñoz Guerrero, Adviser, Sustainable Rural Developmente Directorate, National Planning Department (DNP) (Colombia)
MONDAY, 9 DECEMBER 2013
|
||||
|---|---|---|---|---|
TIME
|
CONFERENCES
|
PARTNERING
|
||
Room 1
|
Room 2
|
|||
| 7:00 AM | 7:30 AM |
DOOR OPENING & REGISTRATION
|
||
| 7:30 AM | 8:00 AM | |||
| 8:00 AM | 8:30 AM |
BIOLATAM 2013 OPENING CEREMONY
|
||
| 8:30 AM | 9:00 AM | |||
| 9:00 AM | 9:30 AM |
VENTURE CAPITAL SEMINAR
Part 1: Public policies to support biotech Venture Capital |
ONE-TO-ONE MEETINGS
|
|
| 9:30 AM | 10:00 AM | |||
| 10:00 AM | 10:30 AM | |||
| 10:30 AM | 11:00 AM |
VENTURE CAPITAL SEMINAR
Part 2: Biotech Venture Capital, the experience of international investors |
BIOSIMILARS |
|
| 11:00 AM | 11:30 AM | |||
| 11:30 AM | 12:00 PM | |||
| 12:00 PM | 12:30 PM |
LUNCH
(will not be provided by the event) |
||
| 12:30 PM | 1:00 PM | |||
| 1:00 PM | 1:30 PM | |||
| 1:30 PM | 2:00 PM |
VENTURE CAPITAL SEMINAR
Part 3: What investors seek in the latinamerican biotechnology |
PERSONALIZED MEDICINE BASED ON BIOMARKERS AGAINST CANCER
|
|
| 2:00 PM | 2:30 PM | |||
| 2:30 PM | 3:00 PM | |||
| 3:00 PM | 3:30 PM |
TOWARDS A SUSTAINABLE BIOECONOMY FOR LATIN AMERICA
|
ADVANCED THERAPIES
|
|
| 3:30 PM | 4:00 PM | |||
| 4:00 PM | 4:30 PM | |||
| 4:30 PM | 5:00 PM |
AGROBIOTECHNOLOGY
|
BIOBASED MEDICAL DEVICES
|
|
| 5:00 PM | 5:30 PM | |||
| 5:30 PM | 6:00 PM | |||
| 6:00 PM | 6:30 PM | |||
TUESDAY, 10 DECEMBER 2013
|
|||||
|---|---|---|---|---|---|
TIME
|
CONFERENCES
|
PARTNERING
|
|||
Room 1
|
Room 2
|
||||
| 7:30 AM | 8:00 AM |
DOOR OPENING & REGISTRATION
|
|||
| 8:00 AM | 8:30 AM |
BIOTECHNOLOGY FOR COSMETICS
|
NEGLECTED DISEASES
|
ONE-TO-ONE MEETINGS
|
|
| 8:30 AM | 9:00 AM | ||||
| 9:00 AM | 9:30 AM | ||||
| 9:30 AM | 10:00 AM |
LATIN DIASPORA: SUCCESSFUL LATINAMERICAN BIOENTREPRENEURS AROUND THE WORLD
|
FOOD BIOTECHNOLOGY, THE BIG BET
|
||
| 10:00 AM | 10:30 AM | ||||
| 10:30 AM | 11:00 AM | ||||
| 11:00 AM | 11:30 AM |
BIOPROSPECTING AND BIODIVERSITY
|
THE IMPACT OF BIOTECHNOLOGY IN ANIMAL HEALTH AND AQUACULTURE
|
||
| 11:30 AM | 12:00 PM | ||||
| 12:00 PM | 12:30 PM | ||||
| 12:30 PM | 1:00 PM |
LUNCH
(will not be provided by the event) |
|||
| 1:00 PM | 1:30 PM | ||||
| 1:30 PM | 2:00 PM | ||||
| 2:00 PM | 2:30 PM |
GOOD MARKET ACCESS PRACTICES IN LATAM
|
BIOENTREPENEURIAL
IN COLOMBIA |
||
| 2:30 PM | 3:00 PM | ||||
| 3:00 PM | 3:30 PM | ||||
| 3:30 PM | 4:00 PM |
BIOTECH CLUSTER POLICIES IN LATIN AMERICA
|
|||
| 4:00 PM | 4:30 PM | ||||
| 4:30 PM | 5:00 PM | ||||
| 5:00 PM | 5:30 PM | ||||
| 5:30 PM | 6:00 PM | ||||
An 
/ 
event
/ event
Hosted by:
Follow us on:
Institutional sponsors:  |
 |
 |
 |
||
 |
 |
 |
|||
 |
  |
 | |||
ORIGINAL: BioLatAm 2013
No hay comentarios:
Publicar un comentario
Nota: solo los miembros de este blog pueden publicar comentarios.